SAM domain-containing protein 1 (SAMD1) (SAMD1)

SAM domain-containing protein 1 (SAMD1), also known as Atherin, is a chromatin-associated protein that plays a critical role in transcriptional regulation and epigenetic silencing. It is characterized by its sterile alpha motif (SAM) domain, which facilitates protein-protein interactions and DNA binding, specifically targeting unmethylated CpG islands and regions enriched with H3K4me3 (UniProt Q6SPF0). SAMD1 acts as a transcriptional repressor, often working in concert with other chromatin modifiers to maintain gene silencing in specific cellular contexts (PubMed: 32814900). In the context of cardiovascular disease, SAMD1 is identified as Atherin, a protein that accumulates in the intima of human arteries during the early stages of atherosclerosis, suggesting a role in plaque formation (PubMed: 15155818). In oncology, SAMD1 has been implicated in the regulation of cell proliferation and is frequently dysregulated in various cancers, making it a potential target for epigenetic therapy (PubMed: 34153475). Research indicates that SAMD1 may influence the recruitment of Polycomb Repressive Complexes or other histone methyltransferases to specific genomic loci. While no clinical-stage drugs currently target SAMD1, its role in modulating the epigenetic landscape makes it an area of active research for small molecule inhibitor development. Its dual involvement in metabolic/vascular disease and cancer highlights its importance as a multi-functional regulatory protein.

Other names

AtherinSterile alpha motif domain-containing protein 1

Modulation of transcriptional repression through the disruption of SAMD1 binding to unmethylated CpG islands or H3K4me3-modified chromatin.